Growth Hormone Guidelines

a. Revised IAP growth charts for height, weight and body mass index for 5- to 18-year-old Indian children.

Indian Academy of Pediatrics Growth Charts Committee, Khadilkar V, Yadav S, Agrawal KK, Tamboli S, Banerjee M, Cherian A, Goyal JP, Khadilkar A, Kumaravel V, Mohan V, Narayanappa D, Ray I, Yewale V.
Indian Pediatr. 2015 Jan;52(1):47-55.

b. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency.

Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, Rossi WC, Feudtner C, Murad MH; Drug and Therapeutics Committee and Ethics Committee of the Pediatric Endocrine Society.
Horm Res Paediatr. 2016;86(6):361-397. doi: 10.1159/000452150. Epub 2016 Nov 25.

c. Diagnosis and management of Silver-Russell syndrome: first international consensus statement.

Wakeling EL, Brioude F, Lokulo-Sodipe O, O'Connell SM, Salem J, Bliek J, Canton AP, Chrzanowska KH, Davies JH, Dias RP, Dubern B, Elbracht M, Giabicani E, Grimberg A, Grnskov K, Hokken-Koelega AC, Jorge AA, Kagami M, Linglart A, Maghnie M, Mohnike K, Monk D, Moore GE, Murray PG, Ogata T, Petit IO, Russo S, Said E, Toumba M, Tmer Z, Binder G, Eggermann T, Harbison MD, Temple IK, Mackay DJ, Netchine I.
Nat Rev Endocrinol. 2017 Feb;13(2):105-124. doi: 10.1038/nrendo.2016.138. Epub 2016 Sep 2.

d. Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.

Deal CL, Tony M, Hybye C, Allen DB, Tauber M, Christiansen JS; 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants. J ClinEndocrinolMetab. 2013 Jun;98(6):E1072-87. doi: 10.1210/jc.2012-3888. Epub 2013 Mar 29.

e. Recommendations for the diagnosis and management of Prader-Willi syndrome.

Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M; speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS.
J ClinEndocrinolMetab. 2008 Nov;93(11):4183-97. doi: 10.1210/jc.2008-0649. Epub 2008 Aug 12.

f. Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development.

Shulman DI, Francis GL, Palmert MR, Eugster EA; Lawson Wilkins Pediatric Endocrine Society Drug and Therapeutics Committee.
Pediatrics. 2008 Apr;121(4):e975-83. doi: 10.1542/peds.2007-2081.

g. Acromegaly: an endocrine society clinical practice guideline.

Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA; Endocrine Society.
J ClinEndocrinolMetab. 2014 Nov;99(11):3933-51. doi: 10.1210/jc.2014-2700. Epub 2014 Oct 30.

h. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop.

Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM; 2007 ISS Consensus Workshop participants.

J ClinEndocrinolMetab. 2008 Nov;93(11):4210-7. doi: 10.1210/jc.2008-0509. Epub 2008 Sep 9.

i. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium.

Javaid MK, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A, Arundel P, Shaw N, Pos VD, Underhil A, Portero D, Heral L, Heegaard AM, Masi L, Monsell F, Stanton R, Dijkstra PDS, Brandi ML, Chapurlat R, Hamdy NAT, Collins MT.

Orphanet J Rare Dis. 2019 Jun 13;14(1):139. doi: 10.1186/s13023-019-1102-9. Review. Erratum in: Orphanet J Rare Dis. 2019 Nov 21;14(1):267.

j. Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective.

Collett-Solberg PF, Ambler G, Backeljauw PF, Bidlingmaier M, Biller BMK, Boguszewski MCS, Cheung PT, Choong CSY, Cohen LE, Cohen P, Dauber A, Deal CL, Gong C, Hasegawa Y, Hoffman AR, Hofman PL, Horikawa R, Jorge AAL, Juul A, Kamenick P, Khadilkar V, Kopchick JJ, Kristrm B, Lopes MLA, Luo X, Miller

BS, Misra M, Netchine I, Radovick S, Ranke MB, Rogol AD, Rosenfeld RG, Saenger P, Wit JM, Woelfle J.

Horm Res Paediatr. 2019;92(1):1-14. doi: 10.1159/000502231. Epub 2019 Sep 12. Review.

k. Sitting height percentiles in 3-17-year-old Indian children: a multicentre study.

Khadilkar A, Ekbote V, Kajale N, Chiplonkar S, Prasad H, Agarwal S, Singh N, Patwardhan V, Lubree H, Ladkat D, Mandlik R, Vispute S, Palande S, Patel P, Lohiya N, Khadilkar V.

Ann Hum Biol. 2019 Jul 15:1-5.doi: 10.1080/03014460.2019.1637936.

l. Height Velocity Percentiles in Indian Children Aged 5-17 Years.

Khadilkar V, Khadilkar A, Arya A, Ekbote V, Kajale N, Parthasarathy L, Patwardhan V, Phanse S, Chiplonkar S.

Indian Pediatr. 2019 Jan 15;56(1):23-28.

Other Pediatric Endocrine Guidelines

1. CAH/DSD/ Undescended testis

a. Management of Infants with Congenital Adrenal Hyperplasia.

Dabas A, Vats P, Sharma R, Singh P, Seth A, Jain V, Batra P, Gupta N, Kumar R, Kabra M, Kapoor S, Yadav S.

Indian Pediatr. 2020 Feb 15;57(2):159-164

b. Newborn Screening and Diagnosis of Infants with Congenital Adrenal Hyperplasia.

Vats P, Dabas A, Jain V, Seth A, Yadav S, Kabra M, Gupta N, Singh P, Sharma R, Kumar R, Polipalli SK, Batra P, Thelma BK, Kapoor S.

Indian Pediatr. 2020 Jan 15;57(1):49-55.

c. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, Meyer-Bahlburg HFL, Miller WL, Murad MH, Oberfield SE, White PC.

J ClinEndocrinolMetab. 2018 Nov 1;103(11):4043-4088. doi: 10.1210/jc.2018-01865.

d. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ

J ClinEndocrinolMetab. 2016 Feb;101(2):364-89. doi: 10.1210/jc.2015-1710. Epub 2016 Jan 13.

e. Recent Updates on the Diagnosis and Management of Cushing's Syndrome

NiemanLK .EndocrinolMetab (Seoul) 2018 Jun; 33(2): 139-146. Published online 2018 Jun 21. doi: 10.3803/EnM.2018.33.2.139

f. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM.

J ClinEndocrinolMetab. 2008 May;93(5):1526-40. doi: 10.1210/jc.2008-0125. Epub 2008 Mar 11.

g. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A; Endocrine Society.

J ClinEndocrinolMetab. 2015 Aug;100(8):2807-31. doi: 10.1210/jc.2015-1818. Epub 2015 Jul 29.

h. Cushing's syndrome: a practical approach to diagnosis and differential diagnoses.

Pappachan JM, Hariman C, Edavalath M, Waldron J, Hanna FW.

J ClinPathol. 2017 Apr;70(4):350-359. doi: 10.1136/jclinpath-2016-203933. Epub 2017 Jan 9

i. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM.

Eur J Endocrinol. 2016 Aug;175(2):G1-G34. doi: 10.1530/EJE-16-0467.

j. Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015).

Ahmed SF, Achermann JC, Arlt W, Balen A, Conway G, Edwards Z, Elford S, Hughes IA, Izatt L, Krone N, Miles H, O'Toole S, Perry L, Sanders C, Simmonds M, Watt A, Willis D.

ClinEndocrinol (Oxf). 2016 May;84(5):771-88. doi: 10.1111/cen.12857.

k. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.

Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG.

J ClinEndocrinolMetab. 2017 Nov 1;102(11):3869-3903. doi: 10.1210/jc.2017-01658. Erratum in: J ClinEndocrinolMetab. 2018 Feb 1;103(2):699.

l. Statement on gender-affirmative approach to care from the pediatric endocrine society special interest group on transgender health.

Lopez X, Marinkovic M, Eimicke T, Rosenthal SM, Olshan JS; Pediatric Endocrine Society Transgender Health Special Interest Group.

CurrOpinPediatr. 2017 Aug;29(4):475-480. doi: 10.1097/MOP.0000000000000516.

m. Management Of Endocrine Disease: Approach to the management of children and adolescents with Gender Dysphoria.

Martinerie L, Condat A, Bargiacchi A, Bremont-Weill C, de Vries MC, HannemaSE.

Eur J Endocrinol. 2018 Oct 12;179(5):R219-R237. doi: 10.1530/EJE-18-0227. Review.

n. Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care.

Lee PA, Nordenstrom A, Houk CP, Ahmed SF, Auchus R, Baratz A, BaratzDalke K, Liao LM, Lin-Su K, Looijenga LH 3rd, Mazur T, Meyer-Bahlburg HF, Mouriquand P, Quigley CA, Sandberg DE, Vilain E, Witchel S; Global DSD Update Consortium. Horm Res Paediatr. 2016;85(3):158-80. doi: 10.1159/000442975. Epub 2016 Jan 28.Erratum in Horm Res Paediatr. 2016;85(3):180. Koopman, Peter [added].

n. Evaluation and treatment of cryptorchidism: AUA guideline.

Kolon TF, Herndon CD, Baker LA, Baskin LS, Baxter CG, Cheng EY, Diaz M, Lee PA, Seashore CJ, Tasian GE, Barthold JS; American Urological Assocation. J Urol. 2014 Aug;192(2):337-45. doi: 10.1016/j.juro.2014.05.005.

o. Management of disorders of sex development - With a focus on development of the child and adolescent through the pubertal years.

Raza J, Zaidi SZ, Warne GL. Best Pract Res ClinEndocrinolMetab. 2019 Jun;33(3):101297. doi: 10.1016/j.beem.2019.101297. Epub 2019 Jul 27.

p. Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects

Henriette A Delemarre-van de Waal and Peggy T Cohen-Kettenis

q. Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort.

Eggers S, Sadedin S, van den Bergen JA, Robevska G, Ohnesorg T, Hewitt J, Lambeth L, Bouty A, Knarston IM, Tan TY, Cameron F, Werther G, Hutson J, O'Connell M, Grover SR, Heloury Y, Zacharin M, Bergman P, Kimber C, Brown J, Webb N, Hunter MF, Srinivasan S, Titmuss A, Verge CF, Mowat D, Smith G, Smith J, Ewans L, Shalhoub C, Crock P, Cowell C, Leong GM, Ono M, Lafferty AR, Huynh T, Visser U, Choong CS, McKenzie F, Pachter N, Thompson EM, Couper J, Baxendale A, Gecz J, Wheeler BJ, Jefferies C, MacKenzie K, Hofman P, Carter P, King RI, Krausz C, van Ravenswaaij-Arts CM, Looijenga L, Drop S, Riedl S, Cools M, Dawson A, Juniarto AZ, Khadilkar V, Khadilkar A, Bhatia V, Dũng VC, Atta I, Raza J, Thi Diem Chi N, Hao TK, Harley V, Koopman P, Warne G, Faradz S, Oshlack A, Ayers KL, Sinclair AH.

Genome Biol. 2016 Nov 29;17(1):243.

r. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline.

Martin KA, Anderson RR, Chang RJ, Ehrmann DA, Lobo RA, Murad MH, Pugeat MM, Rosenfield RL.

J ClinEndocrinolMetab. 2018 Apr 1;103(4):1233-1257. doi: 10.1210/jc.2018-00241

2. Bone and Calcium Metabolism

a. Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: an update.

Ozel S, Switzer L, Macintosh A, Fehlings D. Dev Med Child Neurol. 2016 Sep;58(9):918-23. doi: 10.1111/dmcn.13196.

b. Approach to the Child with Fractures.

lison M. Boyce, Rachel I. Gafni;,
JCEM 2011 July 1; 96(7): 1943-52, https://doi.org/10.1210/jc.2010-2546

c. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets.

Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, Michigami T, Tiosano D, Mughal MZ, Makitie O, Ramos-Abad L, Ward L, DiMeglio LA, Atapattu N, Cassinelli H, Braegger C, Pettifor JM, Seth A, Idris HW, Bhatia V, Fu J, Goldberg G, Savendahl L, Khadgawat R, Pludowski P, Maddock J, Hypponen E, Oduwole A, Frew E, Aguiar M, Tulchinsky T, Butler G, Hogler W.

J ClinEndocrinolMetab. 2016 Feb;101(2):394-415. doi: 10.1210/jc.2015-2175.

d. Consensus guidelines on the use of bisphosphonate therapy in children and adolescents.

Simm PJ, Biggin A, Zacharin MR, Rodda CP, Tham E, Siafarikas A, Jefferies C, Hofman PL, Jensen DE, Woodhead H, Brown J, Wheeler BJ, Brookes D, Lafferty A, Munns CF; APEG Bone Mineral Working Group. J Paediatr Child Health. 2018 Mar;54(3):223-233. doi: 10.1111/jpc.13768.

e. Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions.

Crabtree NJ, Arabi A, Bachrach LK, Fewtrell M, El-Hajj Fuleihan G, Kecskemethy HH, Jaworski M, Gordon CM; International Society for Clinical Densitometry.

J ClinDensitom. 2014 Apr-Jun;17(2):225-42. doi: 10.1016/j.jocd.2014.01.003.

f. Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics.

g. Bone health in children and adolescents with chronic diseases that may affect the skeleton: the 2013 ISCD Pediatric Official Positions.

Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR, Rosen HN, Weber DR, Zemel BS, Shepherd JA.

J Clin Densitom.2019 Oct-Dec;22(4):453-471. doi: 10.1016/j.jocd.2019.07.001. Epub 2019 Jul 5

Bianchi ML, Leonard MB, Bechtold S, Hogler W, Mughal MZ, Schonau E, Sylvester FA, Vogiatzi M, van den Heuvel-Eibrink MM, Ward L; International Society for Clinical Densitometry.

J ClinDensitom. 2014 Apr-Jun;17(2):281-94. doi: 10.1016/j.jocd.2014.01.005.

h. Management of Osteogenesis Imperfecta.

Ralston SH, Gaston MS.

Front Endocrinol (Lausanne). 2020 Feb 11;10:924. doi: 10.3389/fendo.2019.00924. eCollection 2019. Review.

i. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.

Haffner D, Emma F, Eastwood DM, Duplan MB, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A.

Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5.

j. Therapeutic management of hypophosphatemic rickets from infancy to adulthood.

Linglart A, Biosse-Duplan M, Briot K, Chaussain C, Esterle L, Guillaume-Czitrom S, Kamenicky P, Nevoux J, Pri D, Rothenbuhler A, Wicart P, Harvengt P. Endocr Connect. 2014 Mar 14;3(1):R13-30. doi: 10.1530/EC-13-0103. Print 2014.

k. Management of Hypoparathyroidism: Summary Statement and Guidelines.

Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV, Khan AA, Potts JT Jr.
J ClinEndocrinolMetab. 2016 Jun;101(6):2273-83. doi: 10.1210/jc.2015-3907. Epub 2016 Mar 4.

l. Clinical presentation and management of hypoparathyroidism.

Marcucci G, Cianferotti L, Brandi ML.
Best Pract Res ClinEndocrinolMetab. 2018 Dec;32(6):927-939. doi: 10.1016/j.beem.2018.09.007. Epub 2018 Sep 28.

3. Cancer/ Late effects/ Thalassemia

a. Long-term follow up guidelines for survivors of caner (Children Oncology group 2013) http://www.survivorshipguidelines.org/pdf/LTFUGuidelines_40.pdf

b. Late Effects of Treatments for Childhood Cancer (NIH-National Cancer Institute) https://www.cancer.gov/types/childhood-cancers/late-effects-hp-pdq#link/_1292_toc

c. Hypothalamic-Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society Clinical Practice Guideline.

Sklar CA, Antal Z, Chemaitilly W, Cohen LE, Follin C, Meacham LR, Murad MH.
J ClinEndocrinolMetab. 2018 Aug 1;103(8):2761-2784. doi: 10.1210/jc.2018-01175.

d. Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)

Rajesh V. Thakker, Paul J. Newey, Gerard V. Walls, John Bilezikian, Henning Dralle, Peter R. Ebeling, ShlomoMelmed, Akihiro Sakurai, Francesco Tonelli, Maria Luisa Brandi; The Journal of Clinical Endocrinology & Metabolism, Volume 97, Issue 9, 1 September 2012, Pages 29903011, https://doi.org/10.1210/jc.2012-1230

e. Guidelines for the Management of Transfusion Dependent Thalassaemia

(TDT) [Internet], 3rd Edition , Thalassaemia International Federation; 2014; 48. (Chapter 8 Endocrine Diseases) Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V

f. Paediatric Endocrine Tumours: A Multi-Disciplinary Consensus Statement of Best Practice from a Working Group

Convened Under the Auspices of the BSPED and UKCCSG
(raretumour working groups) Endorsed by the Clinical Committee of the Society for Endocrinology (SfE)
Helen A Spoudeas

4. Diabetes

a. ISPAD Clinical Practice Consensus Guidelines 2018

b. ISPAD Clinical Practice Consensus Guidelines: Fasting during Ramadan by young people with diabetes.

Deeb A, Elbarbary N, Smart CE, Beshyah SA, Habeb A, Kalra S, Al Alwan I, Babiker A, Al Amoudi R, Pulungan AB, Humayun K, Issa U, Jalaludin MY, Sanhay R, Akanov Z, Krogvold L, de Beaufort C

Pediatr Diabetes. 2020 Feb;21(1):5-17. doi: 10.1111/pedi.12920. Epub 2019 Oct 28.

5. Glucose and Pancreas disorders (Non diabetic)

a. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children.

Thornton PS, Stanley CA, De Leon DD, Harris D, Haymond MW, Hussain K, Levitsky LL, Murad MH, Rozance PJ, Simmons RA, Sperling MA, Weinstein DA, White NH, Wolfsdorf JI; Pediatric Endocrine Society.
J Pediatr. 2015 Aug;167(2):238-45. doi: 10.1016/j.jpeds.2015.03.057.

b. Clinical practice guidelines for congenital hyperinsulinism

TohruYorifuji, Reiko Horikawa, Tomonobu Hasegawa, Masanori Adachi, Shun Soneda, Masanori Minagawa, Shinobu Ida, Takeo Yonekura, Yoshiaki Kinoshita, Yutaka Kanamori, Hiroaki Kitagawa, Masato Shinkai, Hideyuki Sasaki, Masaki Nio, (on behalf of The Japanese Society for Pediatric Endocrinology and The Japanese Society of Pediatric Surgeons)

ClinPediatrEndocrinol. 2017; 26(3): 127152.

c. Insulin resistance in children: consensus, perspective, and future directions.

Levy-Marchal C, Arslanian S, Cutfield W, Sinaiko A, Druet C, Marcovecchio ML, Chiarelli F; ESPE-LWPES-ISPAD-APPES-APEG-SLEP- JSPE; Insulin Resistance in Children Consensus Conference Group.
J ClinEndocrinolMetab. 2010 Dec;95(12):5189-98. doi: 10.1210/jc.2010-1047. Epub 2010 Sep 8.

d. The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.

Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, Mungai L, Oral EA, Patni N, Rother KI, von Schnurbein J, Sorkina E, Stanley T, Vigouroux C, Wabitsch M, Williams R, Yorifuji T.
J ClinEndocrinolMetab. 2016 Dec;101(12):4500-4511. Epub 2016 Oct 6.

6. Pituitary and Hypothalamus/ Electrolytes

a. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.

Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA; Endocrine Society.

J ClinEndocrinolMetab. 2011 Feb;96(2):273-88. doi: 10.1210/jc.2010-1692.

b. Craniopharyngioma.

Mller HL

Endocr Rev. 2014 Jun;35(3):513-43. doi: 10.1210/er.2013-1115. Epub 2014 Jan 27.

c. Clinical practice guideline on diagnosis and treatment of hyponatraemia

GoceSpasovski, Raymond Vanholder, Bruno Allolio, DjillaliAnnane, Steve Ball, Daniel Bichet, Guy Decaux, WiebkeFenske, Ewout J Hoorn, Carole Ichai, Michael Joannidis, Alain Soupart, Robert Zietse, Maria Haller, Sabine van der Veer, Wim Van Biesen and EviNagler on behalf of the Hyponatraemia Guideline Development Group Eur J Endocrinol March 1, 2014 170 G1-G47.doi: 10.1530/EJE-13-1020

d. Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline,

Pamela U. Freda, Albert M. Beckers, Laurence Katznelson, Mark E. Molitch, Victor M. Montori, Kalmon D. Post, Mary Lee Vance,

JCEM April 1,2011; 96(4): 894904, https://doi.org/10.1210/jc.2010-1048

e. SOCIETY FOR ENDOCRINOLOGY CLINICAL GUIDANCE: Inpatient management of cranial diabetes insipidus.

Endocr Connect. 2018 Jul;7(7):G8-G11. doi: 10.1530/EC-18-0154. Baldeweg SE, Ball S, Brooke A, Gleeson HK, Levy MJ, Prentice M, Wass J; Society for Endocrinology Clinical Committee.

7. Puberty, Reproduction

a. Adolescent polycystic ovary syndrome according to the international evidence-based guideline.

Pea AS, Witchel SF, Hoeger KM, Oberfield SE, Vogiatzi MG, Misso M, Garad R, Dabadghao P, Teede H BMC Med. 2020 Mar 24;18(1):72. doi: 10.1186/s12916-020-01516-x.

b.Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.

Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK; EndocrineSociety.
J ClinEndocrinolMetab. 2013 Dec;98(12):4565-92. doi: 10.1210/jc.2013-2350. Epub 2013 Oct 22.

c. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence.

Ibez L, Oberfield SE, Witchel S, Auchus RJ, Chang RJ, Codner E, Dabadghao P, Darendeliler F, Elbarbary NS, Gambineri A, Garcia Rudaz C, Hoeger KM, Lpez-Bermejo A, Ong K, Pea AS, Reinehr T, Santoro N, Tena-Sempere M, Tao R, Yildiz BO, Alkhayyat H, Deeb A, Joel D, Horikawa R, de Zegher F, Lee PA.
Horm Res Paediatr. 2017;88(6):371-395. doi: 10.1159/000479371. Epub 2017 Nov 13.

d. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting.

Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, Lin AE, Mauras N, Quigley CA, Rubin K, Sandberg DE, Sas TCJ, Silberbach M, Sderstrm-Anttila V, Stochholm K, van Alfen-van derVelden JA, Woelfle J, Backeljauw PF; International Turner Syndrome Consensus Group.
Eur J Endocrinol. 2017 Sep;177(3):G1-G70. doi: 10.1530/EJE-17-0430

e. Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium.

Bangalore Krishna K, Fuqua JS, Rogol AD, Klein KO, Popovic J, Houk CP, et al Horm Res Paediatr. 2019;91(6):357-372. doi: 10.1159/000501336. Epub 2019 Jul 18.

f. Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes.

Best Pract Res ClinEndocrinolMetab. 2019 Jun;33(3):101273. doi: 10.1016/j.beem.2019.04.007. Epub 2019 Apr 13.
Haddad NG, Eugster EA.

8. Thyroid

a. Newborn Screening Guidelines for Congenital Hypothyroidism in India: Recommendations of the Indian Society for Pediatric and Adolescent Endocrinology (ISPAE) - Part I: Screening and Confirmation of Diagnosis.

Desai MP, Sharma R, Riaz I, Sudhanshu S, Parikh R, Bhatia V.
Indian J Pediatr. 2018 Jun;85(6):440-447. doi: 10.1007/s12098-017-2575-y.

b. Newborn Screening Guidelines for Congenital Hypothyroidism in India: Recommendations of the Indian Society for Pediatric and Adolescent Endocrinology (ISPAE) - Part II: Imaging, Treatment and Follow-up.

Sudhanshu S, Riaz I, Sharma R, Desai MP, Parikh R, Bhatia V.
Indian J Pediatr. 2018 Jun;85(6):448-453. doi: 10.1007/s12098-017-2576-x. Epub 2018 Feb 17.

c. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S; American Thyroid Association Guidelines Task Force.

Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460

d. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.

Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA
Thyroid. 2016 Oct;26(10):1343-1421.

e. Medullary thyroid cancer: management guidelines of the American Thyroid Association.

American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr. Thyroid. 2009 Jun;19(6):565-612. doi: 10.1089/thy.2008.0403.

9. Weight disorders/ Obesity/ Lipid disorders/ Hypertension

a. Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline.

Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, Yanovski JA.
J ClinEndocrinolMetab. 2017 Mar 1;102(3):709-757. doi: 10.1210/jc.2016-2573.

b. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing.

Brian W. McCrindle, Elaine M. Urbina, Barbara A. Dennison, Marc S. Jacobson, Julia Steinberger, Albert P. Rocchini, Laura L. Hayman, Stephen R. Daniels
Circulation. 2007;115:1948-1967. https://doi.org/10.1161/CIRCULATIONAHA.107.181946

c. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute.

Pediatrics. 2011 Dec;128Suppl 5:S213-56. doi: 10.1542/peds.2009-2107C. Epub 2011 Nov 14.

d. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

Lenders JW1, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr; Endocrine Society.
J ClinEndocrinolMetab. 2014 Jun;99(6):1915-42. doi: 10.1210/jc.2014-1498.

e. Screening for Endocrine Hypertension: An Endocrine Society Scientific Statement

William F. Young, David A. Calhoun, Jacques W.M. Lenders, Michael Stowasser, Stephen C. Textor; Endocrine Reviews, Volume 38, Issue 2, 1 April 2017, Pages 103122, https://doi.org/10.1210/er.2017-00054

f. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents.

Flynn JT, Kaelber DC, Baker-Smith CM, et al; subcommittee on screening and management of high blood pressure in children. Pediatrics. 2017 Dec;140(6). pii: e20173035. doi: 10.1542/peds.2017-3035.

g. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma

P F Plouin, L Amar, O M Dekkers, M Fassnacht, A P Gimenez-Roqueplo, J W M Lenders, C Lussey-Lepoutre, O Steichen and on behalf of the Guideline Working Group
Eur J Endocrinol May 1, 2016 174 G1-G10.doi: 10.1530/EJE-16-0033

h. International Waist Circumference Percentile Cutoffs for Central Obesity in Children and Adolescents Aged 6 to 18 Years.

Xi B, Zong X, Kelishadi R, Litwin M, Hong YM, Poh BK, Steffen LM, Galcheva SV, Herter-Aeberli I, Nawarycz T, Krzywińska-Wiewiorowska M, Khadilkar A, Schmidt MD, Neuhauser H, Schienkiewitz A, Kułaga Z, Kim HS, Stawińska-Witoszyńska B, Motlagh ME, Ruzita AT, Iotova VM, Grajda A, Ismail MN, Krzyżaniak A, Heshmat R, Stratev V, Rżdżyńska-Świątkowska A, Ardalan G, Qorbani M, Świąder-Leśniak A, Ostrowska-Nawarycz L, Yotov Y, Ekbote V, Khadilkar V, Venn AJ, Dwyer T, Zhao M, Magnussen CG, Bovet P.
J ClinEndocrinolMetab. 2020 Apr 1;105(4). pii: dgz195. doi: 10.1210/clinem/dgz195.

i. Static cut-points of hypertension and increased arterial stiffness in children and adolescents: The International Childhood Vascular Function Evaluation Consortium.

Zhao M, Mill JG, Yan WL, Hong YM, Skidmore P, Stoner L, Mora-Urda AI, Khadilkar A, Alvim RO, Kim HS, Montero Lpez P, Zhang Y, Saeedi P, Zaniqueli D, Jiang Y, Oliosa PR, de Faria ER, Mu K, Niu DY, Magnussen CG, Xi B.
J ClinHypertens (Greenwich). 2019 Sep;21(9):1335-1342. doi: 10.1111/jch.13642. Epub 2019 Aug 7

j. Body mass index percentiles and elevated blood pressure among children and adolescents.

Wang M, Kelishadi R, Khadilkar A, Mi Hong Y, Nawarycz T, Krzywińska-Wiewiorowska M, Aounallah-Skhiri H, EsmaeilMotlagh M, Soon Kim H, Khadilkar V, Krzyżaniak A, Ben Romdhane H, Heshmat R, Chiplonkar S, Stawińska-Witoszyńska B, El Ati J, Qorbani M, Kajale N, Traissac P, Ostrowska-Nawarycz L, Ardalan G, Ekbote V, Yang L, Zhao M, Liu X, Liang Y, Xi B.
J Hum Hypertens. 2020 Apr;34(4):319-325. doi: 10.1038/s41371-019-0215-x. Epub 2019 Jun 28.

k. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

Berglund L1, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, Stalenhoef AF; Endocrine society.
J ClinEndocrinolMetab. 2012 Sep;97(9):2969-89. doi: 10.1210/jc.2011-3213.

l. Guidance for Pediatric Familial Hypercholesterolemia 2017.

Harada-Shiba M, Ohta T, Ohtake A, Ogura M, Dobashi K, Nohara A, Yamashita S, Yokote K; Joint Working Group by Japan Pediatric Society and Japan Atherosclerosis Society for Making Guidance of Pediatric Familial Hypercholesterolemia.

J AtherosclerThromb. 2018 Jun 1;25(6):539-553. doi: 10.5551/jat.CR002. Epub 2018 Feb 6.